Patients with prostate cancer demonstrated reduced tumor volume and PSA levels, a key marker of prostate cancer progression, and experienced improved urinary function and maintained sexual function ...

Eligible patients had >5 mm International Society of Urological Pathology (ISUP) grade 1 lesions or any ISUP grade 2-3 lesions, prostate specific antigen level ≤20 ng/mL, and age younger than 80.

A recent study among patients with non-metastatic low to intermediate prostate cancer showed outcomes over eight years were similar between focal therapy and radical prostatectomy. “High Intensity ...

For a decade, prostate cancer has been on the rise, and the incidence is expected to increase even more by 2050. While it doesn't always endanger men's lives, it can affect their quality of life ...

He and his colleagues enrolled 115 men from 13 sites in 5 countries. Grade Group 2 or higher prostate cancer was present in 72 (63%) of 115 patients at baseline and 17 (15%) of 111 patients at 1 year.

Prostate cancer is the most diagnosed form of cancer in England, with 55,033 cases identified in 2023, the latest figures show.

William F. Balistreri, MD Disclosures July 19, 2007 0 Question A patient underwent an ultrasound exam that showed evidence of fatty liver; what is the recommended approach to managing this patient?

The study population had a mean age of about 65, PSA value of 8.5 ng/mL, tumor diameter on MRI of 14-15 mm, and prostate volume of 41 mL. More than 70% of patients had ISUP 2 lesions, and about a ...